CSI Market
Sign In | Register

Haemonetics (HAE) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access HAE Annual Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Haemonetics funds operations, investments, and shareholder returns.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 27 2026)
3 Months 		(Mar 28 2026) (Dec 27 2025) (Sep 27 2025) (Jun 28 2025)
Operating Activities
Income33.01
Depreciation & amortization42.51
Amortization of Other Assets11.80
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges2.30
Provision For Loan Losses Expensed0.04
Increase (Decrease) in Inventories1.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation9.31
Income (Loss) from Equity Method Investments-1.00
Financial Instruments and Foreign Currency Transaction0.00
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability-
Reversal Of Interest Expense On Contingent Consideration-
Gain Loss On Divestiture of Business-
Deferred Other Tax Expense Benefit-
Amortization Of Fair Value Inventory Step Up5.81
Gain Loss On Repurchase Of Debt Instrument-
Income taxes0.00
Unrealized Gain (Loss) on Derivatives0.00
Increase (Decrease) in Accounts Receivable-0.30
Increase (Decrease) in Accounts Payable and Accrued Liabilities-12.62
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Taxes-6.10
Other Working Capital12.78
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-40.42
Discontinued operations0.00
Net Cash flow from Operating Activities52.32
Investing Activities
Capital Expenditures-7.91
Sale of Capital Items0.24
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments To Acquire Business Four Net Of Cash Acquired-
Payments To Acquire Business Five Net Of Cash Acquired-
Transfers From Inventory To Fixed Assets-42.59
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Other Investments-9.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Payments to Acquire Equity Method Investments0.00
Proceeds from Divestiture of Businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-5.57
Discontinued operations0.00
Net Cash Flow from Investing Activities-22.23
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-1.56
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.43
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-3.51
Other net-46.88
Employee Stock Ownership Plan E S O P Cash Contributions To E S O P6.10
Payments For Purchase Of Capped Call Related To Convertible Notes-
Proceeds From Issuance Of Long Term Debt Excluding Line Of Credit-
Decrease For Redemption Of Long Term Debt-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-51.53
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow44.65
Total Cash Flow-22.06
4 historic quarters locked

Sign in to unlock the full Haemonetics cash flow history.

Sign In Create Free Account

About Haemonetics Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260627)
  • Filed with the SEC: August 6, 2026
  • Source: hae-20260627.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000313143-26-000120

Figures are derived from filed reports and may be restated. Historical data is subject to revision.